Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Reimagining Health Data Exchange: An Application Programming Interface-Enabled Roadmap for India.
Authors: Authors: Balsari S, Fortenko A, Blaya JA, Gropper A, Jayaram M, Matthan R, Sahasranam R, Shankar M, Sarbadhikari SN, Bierer BE, Mandl KD, Mehendale S, Khanna T.
J Med Internet Res
View full abstract on Pubmed
Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials.
Authors: Authors: Gelinas L, Lynch HF, Largent EA, Shachar C, Cohen IG, Bierer BE.
Ther Innov Regul Sci
View full abstract on Pubmed
On Scarcity and the Value of Clinical Trials.
Authors: Authors: Gelinas L, Lynch HF, Bierer BE, Cohen IG.
Am J Bioeth
View full abstract on Pubmed
A Framework for Ethical Payment to Research Participants.
Authors: Authors: Gelinas L, Largent EA, Cohen IG, Kornetsky S, Bierer BE, Fernandez Lynch H.
N Engl J Med
View full abstract on Pubmed
Sharing and reuse of individual participant data from clinical trials: principles and recommendations.
Authors: Authors: Ohmann C, Banzi R, Canham S, Battaglia S, Matei M, Ariyo C, Becnel L, Bierer B, Bowers S, Clivio L, Dias M, Druml C, Faure H, Fenner M, Galvez J, Ghersi D, Gluud C, Groves T, Houston P, Karam G, Kalra D, Knowles RL, Krleža-Jeric K, Kubiak C, Kuchinke W, Kush R, Lukkarinen A, Marques PS, Newbigging A, O'Callaghan J, Ravaud P, Schlünder I, Shanahan D, Sitter H, Spalding D, Tudur-Smith C, van Reusel P, van Veen EB, Visser GR, Wilson J, Demotes-Mainard J.
BMJ Open
View full abstract on Pubmed
When clinical trials compete: prioritising study recruitment.
Authors: Authors: Gelinas L, Lynch HF, Bierer BE, Cohen IG.
J Med Ethics
View full abstract on Pubmed
Public Engagement, Notice-and-Comment Rulemaking, and the Common Rule.
Authors: Authors: Lynch HF, Cohen IG, Bierer BE.
IRB
View full abstract on Pubmed
The Revised and Final Common Rule: An Unfinished Story.
Authors: Authors: Bierer BE.
IRB
View full abstract on Pubmed
Institutions as an ethical locus of research prioritisation.
Authors: Authors: Gelinas L, Lynch HF, Bierer B, Cohen IG.
J Med Ethics
View full abstract on Pubmed
What do revised U.S. rules mean for human research?
Authors: Authors: Nichols L, Brako L, Rivera SM, Tahmassian A, Jones MF, Pierce HH, Bierer BE.
Science
View full abstract on Pubmed